KRAS and colorectal carcinoma: Although, in some tumors, the expression of cytoplasmic p62 was negatively associated with patients’ survival, in CRC, a favorable prognostic significance of cytoplasmic p62 was found in the mutated K-RAS but not in the wild-type (wt) K-RAS subgroup of patients [75].